Ignite Creation Date:
2024-05-06 @ 8:13 AM
Last Modification Date:
2024-10-26 @ 11:57 AM
Study NCT ID:
NCT02690480
Status:
UNKNOWN
Last Update Posted:
2020-02-05
First Post:
2016-01-05
Brief Title:
Fulvestrant FPlacebo vs FPalbociclib First Line for Postmenopausal Hormone Receptor Advanced Breast Cancer
Sponsor:
Spanish Breast Cancer Research Group
Organization:
Spanish Breast Cancer Research Group
Organization Data
Organization:
Spanish Breast Cancer Research Group
Class:
OTHER
Study ID:
GEICAM2014-12
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Spanish Breast Cancer Research Group
Lead Sponsor Class:
OTHER
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| AstraZeneca | INDUSTRY |